3rd Circ. Doubts Alleged Cancer Risk Devalued Drug

A Third Circuit panel on Wednesday seemed skeptical that a woman who bought and used a weight loss drug suffered financial harm after she found out it could cause cancer, with...

Already a subscriber? Click here to view full article